Business
Digipath's GroSciences Moving Forward with Further Testing for its Patent Pending All-Natural, Plant-Derived Pesticide
Digipath's GroSciences Moving Forward with Further Testing for its Patent Pending All-Natural, Plant-Derived Pesticide.
About this update from Hypha Labs, Inc.
[{"type":"text","content":"\n\n\n\nDigipath's GroSciences Moving Forward with Further Testing for its Patent Pending All-Natural, Plant-Derived Pesticide\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nDigipath's GroSciences Moving Forward with Further Testing for its Patent Pending All-Natural, Plant-Derived Pesticide\nPR Newswire\nBOULDER, Colo., Aug. 14, 2019\n\n\n\nBOULDER, Colo., Aug. 14, 2019 /PRNewswire/ -- Digipath, Inc. (OTCQB: DIGP), a service-oriented independent testing laboratory, data analytics and formulation firm focused on the developing cannabis and hemp markets, is pleased to announce that its GroSciences division has successfully completed preliminary validation testing on its patent pending all-natural, plant-derived pesticide, TERPO+ Broadspectrum. The product could potentially serve an enormous market by protecting cannabis plants against colonization by microorganisms. The testing has also shown that TERPO+ Broadspectrum acts as a treatment for the elimination of microbial bioburden on cannabis and hemp flowers. Microorganisms and microbial bioburden are the largest single factor in cannabis crop loss.\n\n \n \n\n \nTERPO+ Broadspectrum has been developed by GroSciences as a natural, non-synthetic, pest decontamination product for the cannabis and hemp cultivation industry. Recent cannabis flower experiments have demonstrated the effectiveness of the TERPO+ Broadspectrum formulation in rendering cannabis flower samples to be within microbial testing limits in most states. TERPO+ Broadspectrum treatment reduced the measured CFU/g by 91% compared to untreated samples and early testing results suggest TERPO+ Broadspectrum may be an effective microbial solution for hemp and cannabis flower.\n\"The early results for GroSciences' TERPO+ Broadspectrum are remarkable,\" stated Dr. Cindy Orser, Chief Science Officer, Digipath Inc. \"In our preliminary R & D validation test we successfully treated a sample that had previously failed a state microbial test, and after treatment, the plant matter tested at a passing limit. We're very excited to move int...